RecruitingNCT05401227
Studying medicines during ketamine brain imaging in healthy volunteers
About this title
Read the official source — NCT05401227Medication studyAges 18–55United StatesSchizophrenia
Understand this study
Who could participate?
Listed age limits: 18 years to 55 years.
What will I do during this study?
Participants complete a screening period, four days of study medication or placebo (an inactive comparison treatment), two imaging sessions involving ketamine (one at baseline and one on day 4), and a follow-up visit. They are assigned to one of three ketamine dose levels and separately to study drug or placebo.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Visits and schedule
- Two imaging sessions at least seven days apart, plus a follow-up visit
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: October 15, 2022
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 120
- Sponsor
- New York State Psychiatric Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT05401227
- Official title
Show the full official title
Glutamatergic Mechanisms of Psychosis and Target Engagement: Aim2
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
New York
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is New York State Psychiatric Institute, a research institute.
Does this study involve medication?
Yes. The study involves medication, including ketamine, Ts-134 or XT and Placebo.
Who can participate?
Listed age limits: 18 years to 55 years.
Is this study still recruiting?
The registry lists this study as recruiting.
